NCT04917549View on ClinicalTrials.gov

Prevalence of Oral Lesions in COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

June 10, 2021

Study Completion Date

June 10, 2021

Conditions
Oral LesionsCOVID-19Angiotensin-converting Enzyme 2
Interventions
OTHER

detection of oral lesions

oral lesions in patient diagnosed with COVID-19

Trial Locations (1)

33511

Dalia Rasheed Issa, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT04917549 - Prevalence of Oral Lesions in COVID-19 Patients | Biotech Hunter | Biotech Hunter